1. Home
  2. SLBT vs CADL Comparison

SLBT vs CADL Comparison

Compare SLBT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

HOLD

Current Price

$1.35

Market Cap

644.9M

Sector

N/A

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$7.77

Market Cap

641.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLBT
CADL
Founded
N/A
1999
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.9M
641.2M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
SLBT
CADL
Price
$1.35
$7.77
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $22.11
AVG Volume (30 Days)
56.9K
★ 903.1K
Earning Date
N/A
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 58.62
EPS
★ N/A
N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$4.35
52 Week High
$6.25
$14.00

Technical Indicators

Market Signals
Indicator
SLBT
CADL
Relative Strength Index (RSI) 24.71 26.53
Support Level N/A $7.70
Resistance Level $1.75 $9.42
Average True Range (ATR) 0.13 0.50
MACD 0.00 -0.10
Stochastic Oscillator 27.40 5.04

Price Performance

Historical Comparison
SLBT
CADL

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: